Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281.


Fizazi K., Clarke N. W., De Santis M., Uemura H., Fay A. P., Karadurmus N., ...Daha Fazla

Annals of oncology : official journal of the European Society for Medical Oncology, 2026 (SCI-Expanded, Scopus)